470 related articles for article (PubMed ID: 31505793)
21. Thrombin activation of protein C requires prior processing by a liver proprotein convertase.
Essalmani R; Susan-Resiga D; Guillemot J; Kim W; Sachan V; Awan Z; Chamberland A; Asselin MC; Ly K; Desjardins R; Day R; Prat A; Seidah NG
J Biol Chem; 2017 Jun; 292(25):10564-10573. PubMed ID: 28468828
[TBL] [Abstract][Full Text] [Related]
22. Subtilisin-like proprotein convertase paired basic amino acid-cleaving enzyme 4 is required for chondrogenic differentiation in ATDC5 cells.
Yuasa K; Futamatsu G; Kawano T; Muroshita M; Kageyama Y; Taichi H; Ishikawa H; Nagahama M; Matsuda Y; Tsuji A
FEBS J; 2012 Nov; 279(21):3997-4009. PubMed ID: 22925071
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer.
Page RE; Klein-Szanto AJ; Litwin S; Nicolas E; Al-Jumaily R; Alexander P; Godwin AK; Ross EA; Schilder RJ; Bassi DE
Cell Oncol; 2007; 29(4):289-99. PubMed ID: 17641413
[TBL] [Abstract][Full Text] [Related]
24. Proprotein convertases in post-menopausal endometrial cancer: distinctive regulation and non-invasive diagnosis.
Singh H; Heng S; Nicholls PK; Li Y; Tai LT; Jobling T; Salamonsen LA; Nie G
Biochem Biophys Res Commun; 2012 Mar; 419(4):809-14. PubMed ID: 22390935
[TBL] [Abstract][Full Text] [Related]
25. Proprotein convertase genes in Xenopus development.
Nelsen S; Berg L; Wong C; Christian JL
Dev Dyn; 2005 Jul; 233(3):1038-44. PubMed ID: 15844195
[TBL] [Abstract][Full Text] [Related]
26. Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics.
Becker GL; Sielaff F; Than ME; Lindberg I; Routhier S; Day R; Lu Y; Garten W; Steinmetzer T
J Med Chem; 2010 Feb; 53(3):1067-75. PubMed ID: 20038105
[TBL] [Abstract][Full Text] [Related]
27. The multifaceted proprotein convertases: their unique, redundant, complementary, and opposite functions.
Seidah NG; Sadr MS; Chrétien M; Mbikay M
J Biol Chem; 2013 Jul; 288(30):21473-81. PubMed ID: 23775089
[TBL] [Abstract][Full Text] [Related]
28. Characterization of proADAMTS5 processing by proprotein convertases.
Longpré JM; McCulloch DR; Koo BH; Alexander JP; Apte SS; Leduc R
Int J Biochem Cell Biol; 2009 May; 41(5):1116-26. PubMed ID: 18992360
[TBL] [Abstract][Full Text] [Related]
29. Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins.
Nakayama K
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):625-35. PubMed ID: 9599222
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein.
Ozden S; Lucas-Hourani M; Ceccaldi PE; Basak A; Valentine M; Benjannet S; Hamelin J; Jacob Y; Mamchaoui K; Mouly V; Desprès P; Gessain A; Butler-Browne G; Chrétien M; Tangy F; Vidalain PO; Seidah NG
J Biol Chem; 2008 Aug; 283(32):21899-908. PubMed ID: 18559340
[TBL] [Abstract][Full Text] [Related]
31. Proprotein Convertases and the Complement System.
Dobó J; Kocsis A; Dani R; Gál P
Front Immunol; 2022; 13():958121. PubMed ID: 35874789
[TBL] [Abstract][Full Text] [Related]
32. The proprotein convertases are potential targets in the treatment of dyslipidemia.
Seidah NG; Prat A
J Mol Med (Berl); 2007 Jul; 85(7):685-96. PubMed ID: 17351764
[TBL] [Abstract][Full Text] [Related]
33. Proprotein convertases: "master switches" in the regulation of tumor growth and progression.
Bassi DE; Fu J; Lopez de Cicco R; Klein-Szanto AJ
Mol Carcinog; 2005 Nov; 44(3):151-61. PubMed ID: 16167351
[TBL] [Abstract][Full Text] [Related]
34. Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.
Becker GL; Lu Y; Hardes K; Strehlow B; Levesque C; Lindberg I; Sandvig K; Bakowsky U; Day R; Garten W; Steinmetzer T
J Biol Chem; 2012 Jun; 287(26):21992-2003. PubMed ID: 22539349
[TBL] [Abstract][Full Text] [Related]
35. Processing of human toll-like receptor 7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes.
Hipp MM; Shepherd D; Gileadi U; Aichinger MC; Kessler BM; Edelmann MJ; Essalmani R; Seidah NG; Reis e Sousa C; Cerundolo V
Immunity; 2013 Oct; 39(4):711-21. PubMed ID: 24138882
[TBL] [Abstract][Full Text] [Related]
36. What lies ahead for the proprotein convertases?
Seidah NG
Ann N Y Acad Sci; 2011 Mar; 1220():149-61. PubMed ID: 21388412
[TBL] [Abstract][Full Text] [Related]
37. A novel cell-based sensor detecting the activity of individual basic proprotein convertases.
Löw K; Hardes K; Fedeli C; Seidah NG; Constam DB; Pasquato A; Steinmetzer T; Roulin A; Kunz S
FEBS J; 2019 Nov; 286(22):4597-4620. PubMed ID: 31276291
[TBL] [Abstract][Full Text] [Related]
38. Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1.
Lapierre M; Siegfried G; Scamuffa N; Bontemps Y; Calvo F; Seidah NG; Khatib AM
Cancer Res; 2007 Oct; 67(19):9030-4. PubMed ID: 17909005
[TBL] [Abstract][Full Text] [Related]
39. OFF-State-Specific Inhibition of the Proprotein Convertase Furin.
Dahms SO; Haider T; Klebe G; Steinmetzer T; Brandstetter H
ACS Chem Biol; 2021 Sep; 16(9):1692-1700. PubMed ID: 34415722
[TBL] [Abstract][Full Text] [Related]
40. The biology and therapeutic targeting of the proprotein convertases.
Seidah NG; Prat A
Nat Rev Drug Discov; 2012 May; 11(5):367-83. PubMed ID: 22679642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
